Shedding Light on the Shadows: New DOL Rule Targets Pharmacy Benefit Manager Transparency on October 31, 2026 Posted by
The Digital Mirror: How Social Media is Fueling a Silent Epidemic of Diet Culture and Co-Occurring Disorders on October 31, 2026 Posted by
The FY 2027 Budget Proposal: White House Proposes Major Structural Overhaul of Federal Health Agencies on October 31, 2026 Posted by
Bridging the Gap: How the Cancer Research Institute is Defying Uncertainty to Fuel the Future of Immunotherapy on October 31, 2026 Posted by
The ESMO Paradox: Why Positive Clinical Data Is No Longer Enough to Sway Wall Street on October 31, 2026 Posted by
Bridging the Gap: How San Diego State University is Redefining Peer-Led Mental Health Advocacy on October 31, 2026 Posted by
The Clash of Titans: Vietnam vs. Thailand in the ASEAN Championship 2026 Final on October 31, 2026 Posted by
Shedding Light on the Shadows: New DOL Rule Targets Pharmacy Benefit Manager Transparency on October 31, 2026 Posted by
The Digital Mirror: How Social Media is Fueling a Silent Epidemic of Diet Culture and Co-Occurring Disorders on October 31, 2026 Posted by
The FY 2027 Budget Proposal: White House Proposes Major Structural Overhaul of Federal Health Agencies on October 31, 2026 Posted by
Bridging the Gap: How the Cancer Research Institute is Defying Uncertainty to Fuel the Future of Immunotherapy on October 31, 2026 Posted by
Posted in Sleep Health Eli Lilly Finalizes Strategic Acquisition of Centessa Pharmaceuticals: A New Era for Orexin-Based Sleep Medicine on July 13, 2026
Posted in Sleep Health Eli Lilly Bolsters Neuroscience Pipeline with Strategic Acquisition of Centessa Pharmaceuticals on July 2, 2026
Posted in Sleep Health Strategic Expansion: Eli Lilly Finalizes Acquisition of Centessa Pharmaceuticals to Bolster Neuroscience Pipeline on June 25, 2026
Posted in Sleep Health Breakthrough in Cardiometabolic Medicine: Eli Lilly’s Retatrutide Shows Dual Efficacy Against Obesity and Sleep Apnea on June 23, 2026
Posted in Digital Health Tools The 340B Standoff: Eli Lilly’s Enforcement Action Ignites Industry-Wide Conflict on June 23, 2026
Posted in Digital Health Tools A New Frontier in Myelofibrosis: Eli Lilly’s Novel JAK2 Inhibitor Shows Promise in Early Trials on June 21, 2026
Posted in Medical Innovations The 340B Stand-off: Eli Lilly Initiates Retaliatory Measures Against Hospitals Over Claims Data on June 19, 2026
Posted in Medical Innovations Eli Lilly Doubles Down on Non-Opioid Innovation with 4E Therapeutics Acquisition on June 16, 2026
Posted in Medical Innovations Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Market Dominance Following Strong Phase 1 Data on June 16, 2026
Posted in Digital Health Tools Abridge Accelerates AI Integration: Strategic Alliances with Nvidia and Eli Lilly Signal New Era in Clinical Intelligence on June 14, 2026
